Youyi Peng
10Patents
2h-index
14Co-inventors
47Inventor score
Filing activity: Oct 25, 2005 → May 22, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9108949B2 | Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonists | Human Necessities | 4 | Active |
| US9469625B2 | Organic compounds | Human Necessities | 2 | Active |
| US9708294B2 | Organic compounds | Human Necessities | 1 | Active |
| US8143299B2 | Anti-mitotic anti-proliferative compounds | Chemistry; Metallurgy | 1 | Active |
| US8188128B2 | Opioid receptor subtype-selective agents | Chemistry; Metallurgy | 1 | Active |
| US11491150B2 | Organic compounds | Human Necessities | 0 | Active |
| US9452160B2 | Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonists | Human Necessities | 0 | Active |
| US8569350B2 | Anti-mitotic anti-proliferative compounds | Chemistry; Metallurgy | 0 | Active |
| US9944648B2 | Organic compounds | Chemistry; Metallurgy | 0 | Active |
| US10851096B2 | Aryl and heteroaryl amides for use as anti-proliferative, anti-thrombotic, and anti-viral agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.